Details for New Drug Application (NDA): 213682
✉ Email this page to a colleague
NDA 213682 describes SACUBITRIL AND VALSARTAN, which is a drug marketed by Alembic, Alkem Labs Ltd, Biocon Pharma, Crystal, Laurus, MSN, Torrent, and Zydus Pharms, and is included in eight NDAs. It is available from three suppliers. Additional details are available on the SACUBITRIL AND VALSARTAN profile page.
The generic ingredient in SACUBITRIL AND VALSARTAN is sacubitril; valsartan. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the sacubitril; valsartan profile page.
The generic ingredient in SACUBITRIL AND VALSARTAN is sacubitril; valsartan. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the sacubitril; valsartan profile page.
Summary for 213682
| Tradename: | SACUBITRIL AND VALSARTAN |
| Applicant: | Alembic |
| Ingredient: | sacubitril; valsartan |
| Patents: | 0 |
Pharmacology for NDA: 213682
| Mechanism of Action | Angiotensin 2 Receptor Antagonists Neprilysin Inhibitors |
Suppliers and Packaging for NDA: 213682
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SACUBITRIL AND VALSARTAN | sacubitril; valsartan | TABLET;ORAL | 213682 | ANDA | Alembic Pharmaceuticals Limited | 46708-556 | 46708-556-10 | 100 BLISTER PACK in 1 CARTON (46708-556-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| SACUBITRIL AND VALSARTAN | sacubitril; valsartan | TABLET;ORAL | 213682 | ANDA | Alembic Pharmaceuticals Limited | 46708-556 | 46708-556-45 | 180 TABLET, FILM COATED in 1 BOTTLE (46708-556-45) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 24MG;26MG | ||||
| Approval Date: | May 28, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 49MG;51MG | ||||
| Approval Date: | May 28, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 97MG;103MG | ||||
| Approval Date: | May 28, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
